Effect of a Free Sulphydryl Group on Expression of HLA-B27 Specificity
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 19 (sup87) , 44-50
- https://doi.org/10.3109/03009749009097057
Abstract
Sequence studies indicate that the α-1 domain of the HLA-B27 molecule has a characteristic unpaired cysteine residue at position 67, adjacent, because of secondary structure, to a lysine at position 70. Simple chemical considerations predict that this cysteine should have an exceptionally reactive sulphydryl group. We have shown by ELISA and flow cytometry that the binding of some monoclonal antibodies to B27 on lymphoid cell lines can be inhibited by reagents which react with sulphydryl groups. However this inhibition is never complete: the evidence suggests 2 forms of B27 molecule, one of which is already blocked. We propose that some HLA molecules with oxidised sulphydryls are recognised as different from the reduced forms. Whether they are also recognised as foreign will depend on an individual's history of thymic learning. Oxidation to 'foreign' HLA in the adult is likely to predispose to inflammatory reactions.Keywords
This publication has 18 references indexed in Scilit:
- Guilt by association: HLA-B27 and ankylosing spondylitisImmunology Today, 1990
- THE ROLE OF HLA-B27 IN ARTHRITISRheumatology, 1988
- Nature of polymorphism in HLA-A, -B, and -C molecules.Proceedings of the National Academy of Sciences, 1988
- Response to the editorial by Terasaki and YuArthritis & Rheumatism, 1987
- Regarding the ankylosing spondylitis/klebsiella/hla–b27 problemArthritis & Rheumatism, 1987
- Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3Human Immunology, 1983
- HLA‐B27, Klebsiella and Ankylosing Spondylitis: Biological and Chemical StudiesImmunological Reviews, 1983
- Increased responsiveness of rheumatoid B lymphocytes to stimulation by epstein-barr virusRheumatology International, 1983
- Monoclonal antibody (B27M2) subdividing HLA-B27Human Immunology, 1982
- MONOCLONAL ANTI-HLA-B27 ANTIBODY (B27M1): PRODUCTION AND LACK OF DETECTABLE TYPING DIFFERENCE BETWEEN PATIENTS WITH ANKYLOSING SPONDYLITIS, REITER'S SYNDROME, AND NORMAL CONTROLSThe Lancet, 1981